Both in Pharmaceuticals
Tilray Brands vs CorMedix
Over the past year TLRY returned −77.3% and CRMD returned −51.1%; their daily moves had a correlation of 0.11.
TLRY −77.3% CRMD −51.1%Growth of $1, one year, split-adjusted
| Metric | TLRY | CRMD |
|---|---|---|
| Price | $2.97 | $5.64 |
| Market cap | $438.9M | $439.6M |
| Today | +12.08% | +1.44% |
| 1 month | −21.4% | −22.5% |
| 6 months | −48.4% | −29.9% |
| Year to date | −67.1% | −51.5% |
| 1 year | −77.3% | −51.1% |
| Revenue growth (YoY) | +22.7% | +156.5% |
| Gross margin | 30.1% | 75.7% |
| Net margin | −16.8% | 25.5% |
| P/E (TTM) | — | 2.3× |
| Price / sales | 0.5× | 1.0× |
| Net cash | $16.6M | $256.7M |
| Dividend yield | — | — |
| Volatility (60d) | 50.5% | 77.2% |
| Short % of float | 14.6% | 20.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).